A Phase I trial of PVSRIPO for Patients with Unresectable Melanoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
October 24, 2018
End Date
February 10, 2022
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
October 24, 2018
End Date
February 10, 2022